Small Grants Program

小额赠款计划

• 批准号: 10576207
• 负责人: RICHARD YANAGIHARA
• 金额: $ 19.35万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-03-14 至 2023-07-13
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10576207
• 关键词: Affect; Applications Grants; Asia; Award; Basic Science; Biomedical Research; Center for Translational Science Activities; Centers of Research Excellence; Cessation of life; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communicable Diseases; Data; Development; Diagnostic; Economics; Emerging Communicable Diseases; Epidemic; Extramural Activities; Faculty; Fostering; Funding; Funding Mechanisms; Geographic Locations; Goals; Grant; Guidelines; Hawaii; Infectious Diseases Research; International; Investments; Measures; Mentors; Phase; Phase Transition; Pilot Projects; Prevention strategy; Probability; Process; Productivity; Rapid diagnostics; Research; Research Training; Resource Sharing; Resources; Schools; Science; Scientist; Series; Site; Social Behavior; Talents; Time; Training; Training Programs; Translational Research; Travel; United States National Institutes of Health; Universities; Vaccines; Vision; Work; base; career; career development; clinical infrastructure; data sharing; design; effective therapy; epidemiology study; expectation; experience; flexibility; human capital; improved; meetings; programs; prospective; success; therapeutically effective; translational research program; underserved community

Project Summary for the Small Grants Program During Phases I and II of Centers of Biomedical Research Excellence (COBRE) funding, the Pacific Center for Emerging Infectious Diseases Research (http://pceidr.jabsom.hawaii.edu/) was transformed into a translational science center of excellence for the development of rapid diagnostics, effective therapeutics and affordable vaccines for infectious diseases, that disproportionately affect underserved communities in the Asia-Pacific region. The overall objective of the Phase III COBRE is to enhance the conditions that accelerate the pace of scientific discovery, heighten research productivity and increase competitiveness for extramural funding by sustaining the COBRE cores and implementing a collaborative Small Grants Program. The proposed Small Grants Program will embrace the key tenets of the IDeA Program: namely, to foster collaborative interactions; promote data and resource sharing; identify and disseminate best practices; and develop strategies to identify additional opportunities for core sustainability. Thus, the COBRE Small Grants Program will harness the rich human capital and exceptional core resources at COBRE, IDeA Networks of Biomedical Research Excellence (INBRE) and Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR) programs to conduct team-science research on emerging infectious diseases. To be more responsive to the needs of faculty at different career stages and provide additional opportunities for mentoring and specialized training, the Small Grants Program will offer modest support on a competitive basis through three distinct funding mechanisms: (1) Pilot Projects Program; (2) Bridging Funds Program; and (3) Faculty Exchange Program. A rigorous application and review process, designed according to NIH guidelines, will be implemented to identify the most meritorious science and to select the applicants with the greatest potential for long-term success. At the same time, COBRE Mentors will also provide personalized mentoring to unfunded applicants, thereby optimizing the professional development of local talent for careers in infectious diseases research. Based on our experience in managing collaborative pilot projects and bridging funds program in other NIH center grants, the expectation is that the proposed Small Grants Program will have a significant impact on heightening research productivity and enhancing grants success. A significant return on investment, as measured by extramural funding in the form of R-, U- and K-series grants, will serve as the scientific and economic engines to drive future research and funding to sustain the Center and its cores.

小额赠款计划项目摘要 在生物医学卓越研究中心 (COBRE) 资助的第一阶段和第二阶段期间，太平洋中心 新发传染病研究 (http://pceidr.jabsom.hawaii.edu/) 转变为转化研究 卓越科学中心，致力于开发快速诊断、有效治疗和负担得起的药物 传染病疫苗对亚太地区服务不足的社区造成不成比例的影响 地区。第三阶段 COBRE 的总体目标是改善加快步伐的条件 科学发现，提高研究生产力并提高外部资金的竞争力 维持 COBRE 核心并实施协作小额赠款计划。拟议的小型 赠款计划将遵循 IDeA 计划的关键原则：即促进协作互动； 促进数据和资源共享；确定并传播最佳实践；并制定策略来识别 核心可持续性的额外机会。 因此，COBRE 小额赠款计划将利用丰富的人力资本和卓越的核心资源 COBRE、IDeA 生物医学卓越研究网络 (INBRE) 和机构发展奖 用于开展团队科学的临床和转化研究项目基础设施 (IDeA-CTR) 项目 新发传染病研究。更好地满足不同职业教师的需求 阶段并提供额外的指导和专门培训机会，小额赠款计划 将通过三种不同的融资机制在竞争的基础上提供适度的支持：(1) 试点项目 程序; (2) 过渡资金计划； (3) 教师交流计划。严格的申请和审查 根据 NIH 指南设计的流程将被实施，以确定最有价值的科学 并选择最有潜力取得长期成功的申请人。与此同时，COBRE 导师还将为没有资金的申请人提供个性化指导，从而优化专业 培养当地传染病研究人才。 基于我们在其他 NIH 管理协作试点项目和过渡资金计划的经验 中心赠款，预计拟议的小额赠款计划将对 提高研究生产力并提高资助成功率。显着的投资回报，因为 通过 R、U 和 K 系列赠款形式的外部资金来衡量，将作为科学和 推动未来研究的经济引擎和维持该中心及其核心的资金。